CN EN
CN EN

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
News Center News Center

News Center

2025.02.13

[News] BaoPharma’s KJ015 Injection (Subcutaneous) Receives Clinical Trial Approval from the NMPA

View details
[News] BaoPharma’s KJ015 Injection (Subcutaneous) Receives Clinical Trial Approval from the NMPA
[News] Bao Pharma Completes Pharmaceutical Excipient Registration for Hyaluronidase
2024.11.21

[News] Bao Pharma Completes Pharmaceutical Excipient Registration for Hyaluronidase

View details
[News] KJ103 (Ricefidase) Designated as a Breakthrough Therapy
2024.11.20

[News] KJ103 (Ricefidase) Designated as a Breakthrough Therapy

View details
[News] Bao Pharma’s “KJ103 for Injection” Receives Clinical Trial Approval from NMPA
2024.08.22

[News] Bao Pharma’s “KJ103 for Injection” Receives Clinical Trial Approval from NMPA

View details
[News] The Investigator Meeting for the Phase II Clinical Trial of KJ103 (Ricefidase) for Anti-GBM Disease Successfully Concludes
2024.07.22

[News] The Investigator Meeting for the Phase II Clinical Trial of KJ103 (Ricefidase) for Anti-GBM Disease Successfully Concludes

View details
12